Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Tiny Corbus looks to take on Vertex with experimental lung drug

    Headlines

    Mon, 4 May 2015

    May 4 (Reuters) - Corbus Pharmaceuticals Holdings Inc's experimental drug for cystic fibrosis, a rare lung-scarring disease, could be a real money spinner and pose a challenge to rival Vertex Pharmaceuticals Inc's successful treatment, Kalydeco.

  2. FDA rejects AcelRx's request for meeting on pain drug device

    Headlines

    Mon, 4 May 2015

    May 4 (Reuters) - AcelRx Pharmaceuticals Inc said a division of the U.S. Food and Drug Administration had rejected the company's request for a meeting to discuss the need for an additional trial of...

  3. Bayer buys rights to Isis Pharma's anti-clotting drug

    Headlines

    Mon, 4 May 2015

    FRANKFURT, May 4 (Reuters) - German drugmaker Bayer secured the rights to an experimental anti-blood-clotting drug in a deal with California-based Isis Pharmaceuticals to bolster its cardiovascular business led by blockbuster pill Xarelto.

  4. BRIEF-Veloxis Pharmaceuticals : Envarsus XR shows improved profile in transplant recipients

    Headlines

    Mon, 4 May 2015

    * Envarsus XR demonstrates improved pharmacokinetic profile in African-American transplant recipients

  5. Shire Reports Solid 1Q on Strong Vyvanse sales; Increasing FVE Modestly

    Commentary

    Thu, 30 Apr 2015

    continue to think the company's growth by acquisition strategy, such as its recent $5.2 billion purchase of NPS Pharmaceuticals reinforces Shire's narrow economic moat, as the deal adds new drugs to its growing rare disease portfolio and leverages

  6. My strategy

    Commentary

    Wed, 29 Apr 2015

    I developed a strategy based on buying high dividend individual stocks. 70% of the portfolio is in large cap telecom, drug companies , utilities, oil and gas adn consumer staples. 30% is in higher yielding REIT and BDC. I generate a 6.0-6.5

  7. FDA could approve drugs for new uses on less data--draft law

    Headlines

    Wed, 29 Apr 2015

    April 29 (Reuters) - Draft U.S. legislation released on Wednesday could make it easier for drug companies to win Food and Drug Administration approval of products for new uses.

  8. UPDATE 2-Ariad Pharma CEO Berger to retire in deal with top investor

    Headlines

    Wed, 29 Apr 2015

    April 29 (Reuters) - Ariad Pharmaceuticals Inc said Chief Executive Harvey Berger would retire as part of a deal to settle a proxy battle with its largest shareholder Sarissa Capital Management.

  9. UPDATE 2-Drugmaker Valeant raises forecasts, says CFO to leave

    Headlines

    Wed, 29 Apr 2015

    April 29 (Reuters) - Drugmaker Valeant Pharmaceuticals International Inc raised its earnings and sales forecasts for the year on Wednesday and said its chief financial officer will step down.

  10. Ariad CEO Berger to step down in settlement deal with Sarissa

    Headlines

    Wed, 29 Apr 2015

    April 29 (Reuters) - Sarissa Capital Management LP said Ariad Pharmaceuticals Inc's Harvey Berger would retire as CEO as part of a deal to settle the hedge funds's proxy battle with the drugmaker.

« Prev12345Next »
Content Partners